Tag: Lynparza for ovarian cancer

New Drug For Ovarian Cancer

The Talcum Powder Lawsuit Helpline is more then just Talcum Powder or Baby Powder lawyers. We keep you updated on the latest ovarian cancer news and treatments. We found this online and hope it helps.

New Drugs for Advanced Ovarian Cancer

In 2014, the Food and Drug Administration (FDA) approved the first of a new class of drugs, called PARP inhibitors, to treat advanced ovarian cancer (cancer that has spread beyond the ovaries and pelvic area).

The new drug, called Lynparza (olaparib), is taken as a pill.

Lynparza is recommended for women with both advanced ovarian cancer and an inherited BRCA1 or BRCA2 gene mutation who have undergone three or more previous rounds of chemo.

In a small clinical trial, about one-third of the women who got the new drug had their tumors shrink or disappear for an average of about eight months.

Talc particles from Talcum powder can travel to the ovaries and cause cancer cells. Ovarian cancer is often fatal. The manufacturers knew about the potential risks and never published a warning or added a warning label. Why? Because Talcum powder and Baby Powder is a multi million dollar industry and was marketed for adult women to use for personal hygiene to keep private areas dry.